FDA pan­dem­ic de­lays strike again with Is­raeli mi­cro­cap the lat­est to re­ceive a CRL based on in­spec­tion set­backs

Is­raeli mi­cro­cap Pro­tal­ix Ther­a­peu­tics and its part­ners at Ital­ian phar­ma com­pa­ny Chiesi re­ceived bad news re­gard­ing their Fab­ry dis­ease pro­gram.

The FDA is­sued the pair …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER